Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST

SHA:600351 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
861.49820.51578.59617.64668.5477.05
Trading Asset Securities
5.07-----
Cash & Short-Term Investments
866.56820.51578.59617.64668.5477.05
Cash Growth
33.73%41.81%-6.32%-7.61%40.13%36.10%
Accounts Receivable
367.19361.99444.15601.32716.18667.79
Other Receivables
14.7920.5143.9535.1470.5991.72
Receivables
381.98382.5488.1636.45786.77759.52
Inventory
294.42315.73413.05442.13449.14521.01
Prepaid Expenses
--0.0100.03-
Other Current Assets
61.4759.3379.5656.8149.939.51
Total Current Assets
1,6041,5781,5591,7531,9541,797
Property, Plant & Equipment
1,0331,0541,2031,3081,3771,454
Long-Term Investments
297.92317.47372.61377.72346.43314.68
Goodwill
26.2726.2726.2726.2726.2774.57
Other Intangible Assets
136.08136.57146.99154.96155.6157.39
Long-Term Deferred Tax Assets
29.5323.8741.8931.234.6128.46
Long-Term Deferred Charges
90.889.05138.28155.8179.27146.35
Other Long-Term Assets
61.160.755.4646.6957.73104.03
Total Assets
3,2793,2863,5443,8544,1314,077
Accounts Payable
129.61126.51153.34191.7166.94120.66
Accrued Expenses
57.4866.9296.17123.09130.69111.71
Short-Term Debt
--90.07200.22410.26502.37
Current Portion of Long-Term Debt
0.670.58-221.011.01
Current Portion of Leases
--3.573.413.283.85
Current Income Taxes Payable
42.5317.724.076.3212.245.99
Current Unearned Revenue
55.9168.3480.4467.32108.4890.2
Other Current Liabilities
123.56105.16154.35191.4187.77169.62
Total Current Liabilities
409.77385.24582.02785.461,0411,005
Long-Term Debt
3535--223
Long-Term Leases
1.180.572.063.375.18.52
Long-Term Unearned Revenue
35.9137.1337.2443.5347.9946.1
Long-Term Deferred Tax Liabilities
3.143.1799.269.9511.36
Other Long-Term Liabilities
--18.7218.7218.7218.72
Total Liabilities
485.01461.11649.02860.331,1241,113
Common Stock
692692720770770770
Additional Paid-In Capital
550.45550.45703.76955.1955.32955.32
Retained Earnings
1,6391,6711,5611,4261,2651,222
Treasury Stock
---66.06-150.45--
Comprehensive Income & Other
-28.86-28.86-25.7-24.41-20.01-20.05
Total Common Equity
2,8532,8842,8932,9762,9702,927
Minority Interest
-58.79-59.112.2817.1236.5636.62
Shareholders' Equity
2,7942,8252,8952,9933,0072,964
Total Liabilities & Equity
3,2793,2863,5443,8544,1314,077
Total Debt
36.8536.1595.7209441.65538.74
Net Cash (Debt)
829.71784.36482.9408.64226.85-61.69
Net Cash Growth
49.61%62.43%18.17%80.14%--
Net Cash Per Share
1.191.120.670.540.29-0.08
Filing Date Shares Outstanding
692.16692.68700720770770
Total Common Shares Outstanding
692.16692.68709.5748.7770770
Working Capital
1,1951,193977.3967.58913.67791.68
Book Value Per Share
4.124.164.083.983.863.80
Tangible Book Value
2,6902,7212,7192,7952,7882,695
Tangible Book Value Per Share
3.893.933.833.733.623.50
Buildings
--1,6311,6131,5971,545
Machinery
--1,3861,3601,3421,340
Construction In Progress
--15.4957.4125.8326.48
Source: S&P Global Market Intelligence. Standard template. Financial Sources.